Advertisement

ADVERTISEMENT

Jolynn Tumolo

News
International Reference Pricing for Prescription Drugs Presents Administrative Complications
10/23/2023
Jolynn Tumolo
The commentary explains that cross-referencing prices between countries is a problem because price changes in one country ripple out to others and compound the effects of the price decrease.
The commentary explains that cross-referencing prices between countries is a problem because price changes in one country ripple out to others and compound the effects of the price decrease.
The commentary explains that...
10/23/2023
Pharmacy Learning Network
News
Few Medicare Providers Offer Intensive Behavioral Therapy for Obesity
10/23/2023
Jolynn Tumolo
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care...
10/23/2023
First Report Managed Care
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
News
No Evidence Stroke, Hypertension Mediates Link Between Air Pollution and Dementia
10/23/2023
Jolynn Tumolo
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not mediate or modify the association between exposure to fine particulate matter air pollution (PM2.5) with incident dementia, according to study results published online in JAMA Network Open. “Although we...
Hypertension and stroke do not...
10/23/2023
Neurology
An illustrated picture shows two cartoon doctors, one holding up a magnifying glass to a cartoon brain.
News
No Disease Activity in Two-Thirds of Patients With Relapsing-Remitting MS a Decade After Stem Cell Therapy
10/19/2023
Jolynn Tumolo
More than half of patients with relapsing-remitting multiple sclerosis (MS) who underwent autologous hematopoietic stem cell transplantation (aHSCT) experienced improved disability.
More than half of patients with relapsing-remitting multiple sclerosis (MS) who underwent autologous hematopoietic stem cell transplantation (aHSCT) experienced improved disability.
More than half of patients with...
10/19/2023
Neurology
stock medication
News
Pilot Study Finds Solriamfetol Beneficial for Adults With ADHD
10/19/2023
Jolynn Tumolo
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug solriamfetol may be an effective treatment for the management of ADHD in adults, according to a pilot study published in the Journal of Clinical Psychiatry.
The wakefulness-promoting drug...
10/19/2023
Psych Congress Network
News
Liquid Plasma Recalled
10/18/2023
Jolynn Tumolo
The FDA has issued a Class II recall for liquid plasma distributed across 17 states.
The FDA has issued a Class II recall for liquid plasma distributed across 17 states.
The FDA has issued a Class II...
10/18/2023
Pharmacy Learning Network
News
Frozen Plasma Recalled
10/18/2023
Jolynn Tumolo
The American National Red Cross recalled one unit of PF 24 plasma, citing improper performance of arm prep. The recall was included in the October 18, 2023, US Food and Drug Administration (FDA) Enforcement Report.
The American National Red Cross recalled one unit of PF 24 plasma, citing improper performance of arm prep. The recall was included in the October 18, 2023, US Food and Drug Administration (FDA) Enforcement Report.
The American National Red Cross...
10/18/2023
Pharmacy Learning Network
News
Antifungal Tablets Under Class I Recall
10/18/2023
Jolynn Tumolo
The FDA has issues a Class I recall for an antifungal prescription drug indicated for treating vulvovaginal candidiasis and reducing the incidence of recurrent vulvovaginal candidiasis.
The FDA has issues a Class I recall for an antifungal prescription drug indicated for treating vulvovaginal candidiasis and reducing the incidence of recurrent vulvovaginal candidiasis.
The FDA has issues a Class I...
10/18/2023
Pharmacy Learning Network
Sad neutral happy faces
News
Newly Approved MDD Drug Does Not Appear to Increase Risk of Sexual Dysfunction
10/18/2023
Jolynn Tumolo
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug Administration (FDA) recently approved Exxua (gepirone hydrochloride extended-release [ER] tablets) for the treatment of major depressive disorder (MDD) in adults.
The US Food and Drug...
10/18/2023
Psych Congress Network
Boys with ADHD
Conference Coverage
ADHD Diagnosis, Recommended Therapy More Likely in Older Children, Boys
10/17/2023
Jolynn Tumolo
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents, older age and male gender were factors associated with receiving a diagnosis as well as recommended ADHD therapy, according to a poster presented at the Child Neurology Society Annual Meeting.
In children and adolescents,...
10/17/2023
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
November 1 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use